414 related articles for article (PubMed ID: 29155816)
1. Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.
Guery R; Henry B; Martin-Blondel G; Rouzaud C; Cordoliani F; Harms G; Gangneux JP; Foulet F; Bourrat E; Baccard M; Morizot G; Consigny PH; Berry A; Blum J; Lortholary O; Buffet P;
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006094. PubMed ID: 29155816
[TBL] [Abstract][Full Text] [Related]
2. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
Solomon M; Pavlotsky F; Leshem E; Ephros M; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):973-7. PubMed ID: 21129042
[TBL] [Abstract][Full Text] [Related]
3. Failure of Liposomal-amphotericin B Treatment for New World Cutaneous Leishmaniasis due to Leishmania braziliensis.
Kosaka A; Sakamoto N; Hikone M; Imai K; Ota M; Washino T; Maeda T; Iwabuchi S
Intern Med; 2020; 59(9):1227-1230. PubMed ID: 32378656
[TBL] [Abstract][Full Text] [Related]
4. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers.
Solomon M; Pavlotzky F; Barzilai A; Schwartz E
J Am Acad Dermatol; 2013 Feb; 68(2):284-9. PubMed ID: 22858005
[TBL] [Abstract][Full Text] [Related]
5. [A multifocal form of cutaneous leishmaniasis caused by Leishmania infantum in an immunocompetent child treated with a short course of liposomal amphotericin B].
Taquin H; Chiaverini C; Marty P; Lacour JP
Ann Dermatol Venereol; 2016 Oct; 143(10):622-624. PubMed ID: 27292718
[TBL] [Abstract][Full Text] [Related]
6. A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia.
López L; Vélez I; Asela C; Cruz C; Alves F; Robledo S; Arana B
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006653. PubMed ID: 30044792
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study.
Santos CR; Tuon FF; Cieslinski J; de Souza RM; Imamura R; Amato VS
PLoS One; 2019; 14(6):e0218786. PubMed ID: 31242231
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and Safety of Amphotericin B Deoxycholate, Amphotericin B Colloidal Dispersion, and Liposomal Amphotericin B as Third-Line Treatments for Cutaneous and Mucocutaneous Leishmaniasis: A Retrospective Study.
Rodríguez Galvis MC; Pérez Franco JE; Casas Vargas MY; Ordoñez Rubiano MF
Am J Trop Med Hyg; 2020 Feb; 102(2):274-279. PubMed ID: 31820708
[TBL] [Abstract][Full Text] [Related]
9. Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.
Basile G; Cristofaro G; Locatello LG; Vellere I; Piccica M; Bresci S; Maggiore G; Gallo O; Novelli A; Di Muccio T; Gramiccia M; Gradoni L; Gaiera G; Bartoloni A; Zammarchi L
Int J Infect Dis; 2020 Aug; 97():204-207. PubMed ID: 32505874
[TBL] [Abstract][Full Text] [Related]
10. Travelers with cutaneous leishmaniasis cured without systemic therapy.
Morizot G; Kendjo E; Mouri O; Thellier M; Pérignon A; Foulet F; Cordoliani F; Bourrat E; Laffitte E; Alcaraz I; Bodak N; Ravel C; Vray M; Grogl M; Mazier D; Caumes E; Lachaud L; Buffet PA;
Clin Infect Dis; 2013 Aug; 57(3):370-80. PubMed ID: 23633111
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment.
Mosimann V; Neumayr A; Hatz C; Blum JA
Infection; 2013 Dec; 41(6):1177-82. PubMed ID: 23835701
[TBL] [Abstract][Full Text] [Related]
12. Old world Leishmania infantum cutaneous leishmaniasis unresponsive to liposomal amphotericin B treated with topical imiquimod.
Hervás JA; Martín-Santiago A; Hervás D; Rojo E; Mena A; Rocamora V; Dueñas J
Pediatr Infect Dis J; 2012 Jan; 31(1):97-100. PubMed ID: 21829140
[TBL] [Abstract][Full Text] [Related]
13. Atypical mucocutaneous involvement with Leishmania donovani.
Pulimood SA; Rupali P; Ajjampur SS; Thomas M; Mehrotra S; Sundar S
Natl Med J India; 2012; 25(3):148-50. PubMed ID: 22963292
[TBL] [Abstract][Full Text] [Related]
14. Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: A case series from Spain.
Pérez-Jacoiste Asín MA; Carrasco-Antón N; Fernández-Ruiz M; San Juan R; Alonso-Moralejo R; González E; Andrés A; López-Medrano F; Aguado JM
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27768239
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective Study.
Cunha MA; Leão AC; de Cassia Soler R; Lindoso JA
Am J Trop Med Hyg; 2015 Dec; 93(6):1214-8. PubMed ID: 26483120
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and treatment response of cutaneous leishmaniasis in North-West Ethiopia.
Fikre H; Mohammed R; Atinafu S; van Griensven J; Diro E
Trop Med Int Health; 2017 Oct; 22(10):1293-1301. PubMed ID: 28712122
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous leishmaniasis treated with ambisome (liposomal amphotericin B)].
Ben-Shimol S; Sagi O; Schwartz E; Greenberg D
Harefuah; 2012 Aug; 151(8):458-60, 498. PubMed ID: 23350289
[TBL] [Abstract][Full Text] [Related]
18. Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis.
Jaafari MR; Hatamipour M; Alavizadeh SH; Abbasi A; Saberi Z; Rafati S; Taslimi Y; Mohammadi AM; Khamesipour A
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():156-165. PubMed ID: 31582344
[TBL] [Abstract][Full Text] [Related]
19. Rapidly progressing facial leishmaniasis: effective treatment with liposomal amphotericin B and a review of the management of Old World cutaneous leishmaniasis.
Islam S
Paediatr Int Child Health; 2018 May; 38(2):158-161. PubMed ID: 28281913
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.
Garrido-Jareño M; Sahuquillo-Torralba A; Chouman-Arcas R; Castro-Hernández I; Molina-Moreno JM; Llavador-Ros M; Gómez-Ruiz MD; López-Hontangas JL; Botella-Estrada R; Salavert-Lleti M; Pemán-García J
Parasit Vectors; 2020 Jan; 13(1):24. PubMed ID: 31931865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
